Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
Vox Sang. 2012 Jul;103(1):42-8. doi: 10.1111/j.1423-0410.2011.01577.x. Epub 2012 Jan 11.
There is growing interest in the clinical application of red blood cell (RBC) microparticle (MP) enumeration as they have been postulated to be effectors of coagulation and inflammation following transfusion and in sickle cell disease. No uniform approach in MP enumeration exists and a key limitation is the lack of an internal validation process. We present and validate a flow cytometric approach where an internal standard is utilized.
Glycophorin A(+) Annexin V(+) events were enumerated using MPs isolated from RBC units or plasma samples obtained from volunteers. A mixture of absolute counting (7·6 μm) and calibration beads (0·5, 0·9 and 3 μm) at a fixed ratio was added to each sample.
RBC MPs were initially selected based upon a fluorescence threshold, and the 0·5- and 0·9-μm beads defined the upper and lower light scatter distribution of MPs. The ratio of 7·6:3-μm bead events was used as an internal standard to validate the precision of MP enumeration across samples (coefficient of variation = 2·5-7·2%) and remained constant in both platelet-rich plasma (PRP) and platelet-free plasma (PFP). RBC MP counts increased in both PRP and PFP obtained from whole blood stimulated with ionophore and increasing calcium concentrations, with PRP showing higher MP counts than PFP at every concentration studied.
This method is a useful strategy to detect RBC MP counts across bio-samples provided that the flow cytometer can reliably discriminate the size of the calibration beads.
人们对红细胞(RBC)微粒(MP)计数的临床应用越来越感兴趣,因为它们被认为是输血后凝血和炎症的效应物,并且在镰状细胞病中也是如此。目前尚不存在用于 MP 计数的统一方法,其主要限制因素是缺乏内部验证过程。我们提出并验证了一种使用内部标准的流式细胞术方法。
使用从 RBC 单位或志愿者血浆样本中分离的 MPs,对糖蛋白 A(+) Annexin V(+)事件进行计数。将绝对计数(7.6 μm)和校准珠(0.5、0.9 和 3 μm)的混合物以固定比例添加到每个样本中。
最初根据荧光阈值选择 RBC MPs,而 0.5 和 0.9 μm 珠则定义了 MPs 的上下光散射分布。7.6:3 μm 珠事件的比例被用作内部标准,以验证跨样本的 MP 计数的精密度(变异系数为 2.5-7.2%),并且在富含血小板的血浆(PRP)和无血小板血浆(PFP)中均保持不变。在用离子载体和增加的钙浓度刺激全血获得的 PRP 和 PFP 中,RBC MP 计数均增加,并且在研究的每个浓度下,PRP 中的 MP 计数均高于 PFP。
只要流式细胞仪能够可靠地区分校准珠的大小,该方法就是一种用于在生物样本中检测 RBC MP 计数的有用策略。